American Bitcoin reported a $126 million net profit in Q3 2026, reversing a $57.2 million loss in Q2. The profit was mainly driven by a $197.3 million gain in the value of its Bitcoin holdings as Bitcoin's price rose significantly. However, mining revenue declined to $63.4 million due to lower Bitcoin production and higher electricity costs, which reduced gross margin to 41%. The company increased its Bitcoin reserve to 8,427 BTC without buying new coins, relying on mining output, while adjusted EBITDA improved to $220.8 million despite a $64.3 million loss on derivatives.
Eric Trump's American Bitcoin is the subject, with Pluang market data providing context. For readers following cryptocurrencies, here is Pluang's market snapshot as of Nov 05, 2026 17:21 WIB: out of 50 major cryptocurrencies, 40 rose and 9 fell today. Ethereum (ETH) rose 3.98% to Rp43,890,009 with a typical hold time of 108 days, Solana (SOL) increased 3.97% to Rp1,759,940 with a 72-day hold time, and Cardano (ADA) gained 3.92% to Rp3,608 with a 128-day hold time. Notably, ETH shows a 69% sell order activity contrasting ADA's 65% buy activity.
On November 4, 2026, Shell plc repurchased a total of 1,876,276 shares across multiple trading venues including LSE, Chi-X, BATS, XAMS, CBOE, and TQEX. The shares were bought at prices ranging from £37.98 to £38.82 and €45.70 to €46.72, with an avera...
Dune has completed a SOC 2 Type II examination with no exceptions, providing institutional clients with verified assurance of its data security standards. This milestone comes as tokenized real-world assets doubled to $32.6 billion and stablecoin mar...
Northern Discovery Metals has finalized the acquisition of a 100% interest in the Cibola copper-gold project in British Columbia from Orogen Royalties. The project covers about 3,567 hectares near Houston, BC, in a region known for porphyry copper de...
Opus Genetics has finished dosing the higher-dose Cohort 2 in its Phase 1/2 trial of OPGx-BEST1, a gene therapy for BEST1-related inherited retinal diseases like Best vitelliform macular dystrophy and autosomal recessive bestrophinopathy. Cohort 2 en...
Perimeter Group Inc. announced a net income of $304.5 million for Q3 2026, reversing a prior year loss of $90.7 million, with net sales up 24% to $389.9 million. Growth was driven by a 14% increase in Fire Safety sales and an 84% surge in Specialty P...
